Abstract:Abstract Background Contemporaneous data are required for women with chronic kidney disease (CKD) Stages 3–5 to inform pre-pregnancy counselling and institute appropriate antenatal surveillance. Methods A retrospective cohort study in women with CKD Stages 3–5 after 20 weeks’ gestation was undertaken in six UK tertiary renal centres in the UK between 2003 and 2017. Factors predicting adverse outcomes and the impact of pregnancy in accelerating the need for renal replacement therapy (RRT) were assessed. Results There were 178 pregnancies in 159 women, including 43 women with renal transplants. The live birth rate was 98%, but 56% of babies were born preterm (before 37 weeks’ gestation). Chronic hypertension was the strongest predictor of delivery before 34 weeks’ gestation. Of 121 women with known pre-pregnancy hypertension status, the incidence of delivery before 34 weeks was 32% (31/96) in women with confirmed chronic hypertension compared with 0% (0/25) in normotensive women. The risk of delivery before 34 weeks doubled in women with chronic hypertension from 20% [95% confidence interval (CI) 9–36%] to 40% (95% CI 26–56%) if the gestational fall in serum creatinine was <10% of pre-pregnancy concentrations. Women with a urinary protein:creatinine ratio >100 mg/mmol prior to pregnancy or before 20 weeks’ gestation had an increased risk for birthweight below the 10th centile (odds ratio 2.57, 95% CI 1.20–5.53). There was a measurable drop in estimated glomerular filtration rate (eGFR) between pre-pregnancy and post-partum values (4.5 mL/min/1.73 m2), which was greater than the annual decline in eGFR prior to pregnancy (1.8 mL/min/1.73 m2/year). The effect of pregnancy was, therefore, equivalent to 1.7, 2.1 and 4.9 years of pre-pregnancy renal disease in CKD Stages 3a, 3b and 4–5, respectively. The pregnancy-associated decline in renal function was greater in women with chronic hypertension and in those with a gestational fall in serum creatinine of <10% of pre-pregnancy concentrations. At 1 year post-partum, 46% (58/126) of women had lost ≥25% of their pre-pregnancy eGFR or required RRT. Most women with renal transplants had CKD Stage 3 and more stable renal function prior to pregnancy. Renal transplantation was not independently associated with adverse obstetric or renal outcomes. Conclusions Contemporary pregnancies in women with CKD Stages 3–5 are complicated by preterm delivery, low birthweight and loss of maternal renal function. Chronic hypertension, pre- or early pregnancy proteinuria and a gestational fall in serum creatinine of <10% of pre-pregnancy values are more important predictors of adverse obstetric and renal outcome than CKD Stages 3–5. Pregnancy in women with CKD Stages 3–5 advances the need for dialysis or transplantation by 2.5 years.

Maternal and neonatal outcomes in kidney transplant recipients: a single-center observational study

Maternal and neonatal outcomes for kidney transplant recipients

A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes

Pregnancy outcomes in women with kidney transplant: Metaanalysis and systematic review

Pregnancy outcomes in renal transplant recipients: A systematic review and meta-analysis

Pregnancy Outcomes in Female Kidney Transplant Recipients and Follow-Up of the Health Status of the Offspring

Pregnancy outcomes post‐kidney transplantation across 23 years

Aretrospective cohort study of pregnancy after kidney transplantation

Pregnancy after renal transplantation: report of 3 cases and review of the literature

Influence of pregnancy on graft after renal transplantation

Long-Term Kidney and Maternal Outcomes After Pregnancy in Living Kidney Donors

Pregnancy after kidney and liver transplantation

Early neonatal outcomes in infants of mothers with organ transplantation under immunosuppressive treatment

The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes

Pregnancy after Renal Transplantation: 5 Cases Report

Reproductive Health in Kidney Transplant Recipients

Timing, Conditions, and Complications of Post-operative Conception and Pregnancy in Female Renal Transplant Recipients

Clinical Analysis of 2520 Renal Transplantations in One Center

Family Planning and Assessment of the Frequency of Exposure to Drugs Contraindicated in Pregnancies After Kidney or Liver Transplantation: A Retrospective Cross-Sectional Study

Maternal and Live-birth Outcomes of Pregnancies Following Assisted Reproductive Technology: A Retrospective Cohort Study

Outcome of living renal transplantation:mother-to-child in comparison to father-to-child